Results 161 to 170 of about 151,232 (337)
AbstractPeriodontitis is a complex inflammatory disease in which the host genome, in conjunction with extrinsic factors, determines susceptibility and progression. Genetic predisposition is the strongest risk factor in the first decades of life. As people age, chronic exposure to the periodontal microbiome puts a strain on the proper maintenance of ...
Arne S. Schaefer +4 more
wiley +1 more source
Abstract Background Cryoprecipitate Anti‐Haemophilic Factor (CRYO‐AHF) is enriched for fibrinogen, VWF, FVIII, FXIII and fibronectin, but has short post‐thaw expiration due to risk of transfusion‐transmitted infection (TTI) limiting availability for rapid treatment.
Florian Tupin +6 more
wiley +1 more source
Von Willebrand disease: classification and epidemiology. [PDF]
Castaman G, Bramante Federici A.
europepmc +1 more source
Clinical and laboratory diagnosis of von Willebrand disease. [PDF]
Tosetto A, Eikenboom J.
europepmc +1 more source
Hemostatic effect of normal platelet transfusion in severe von Willebrand disease patients [PDF]
R. Castillo +5 more
openalex +1 more source
ABSTRACT Background In humans, deficiency of a disintegrin‐like and metalloprotease with thrombospondin type 1 motifs, number 13 (ADAMTS13), a von Willebrand factor (vWF) cleaving protease, is an underlying mechanism for thrombosis. The role of ADAMTS13 in canine thromboembolic disease is largely unknown.
Ashley R. Wilkinson +2 more
wiley +1 more source
Historical, current and future treatments for von Willebrand disease. [PDF]
Casari C, Leebeek FWG, Peyvandi F.
europepmc +1 more source
B‐Cell Chronic Lymphocytic Leukemia in a Cat
ABSTRACT Background An 8.8‐year‐old male neutered Persian cat was presented with a history of recent intermittent mild lethargy, hyporexia, and weight loss. Physical examination revealed pale mucous membranes, an enlarged right mandibular lymph node, and organomegaly suspected to be an enlarged spleen.
James Andre Mori +3 more
wiley +1 more source
Surgical intervention with cardiopulmonary bypass in a patient with von Willebrand disease. [PDF]
Loskutov OA +7 more
europepmc +1 more source
Outcomes and Healthcare Resource Utilisation in Adults With von Willebrand Disease Receiving On-Demand Recombinant von Willebrand Factor in the United Kingdom. [PDF]
ABSTRACT Objectives We describe treatment outcomes and healthcare resource utilisation (HCRU) in adults with von Willebrand disease (VWD) treated on demand with recombinant von Willebrand factor (rVWF) in the United Kingdom. Methods Retrospective chart review of adults (≥ 18 years) with congenital VWD receiving first‐time rVWF for the on‐demand ...
Laffan M +6 more
europepmc +2 more sources

